Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Case Report

Citalopram-Associated Alopecia: A Case Report and Brief Literature Review

Author(s): Joshua Hekmatjah*, Kinza Tareen and Ruqiya Shama Tareen

Volume 14, Issue 2, 2019

Page: [167 - 170] Pages: 4

DOI: 10.2174/1574886314666190215115857

Price: $65


Background: Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line treatments for various psychiatric disorders. SSRIs offer an improved side effect profile compared to older treatments, which improves patients’ adherence and quality of life.

Case Report: Here we discuss a case of an uncommon, but a distressing side effect of citalopram. A 76-year old woman was referred to the psychiatry clinic for bizarre behavior. The patient was diagnosed with behavioral variant frontotemporal dementia and was started on citalopram 20 mg and aripiprazole 5 mg daily. At 3.5 months the patient complained of diffuse hair thinning on her scalp. Citalopram was considered the offending agent and was discontinued. Within a few months, the patient regained most of her hair. Although drug-induced alopecia is common among other SSRIs, it is relatively rare with citalopram.

Results and Conclusion: Early recognition, withdrawal of offending agent, and reassurance to the patient that hair loss is reversible can help alleviate patient distress and avoid relapse.

Keywords: Alopecia, SSRIs, adverse drug reactions, citalopram, VIGIBASE, Fluoxetine.

Graphical Abstract
Popovic D, Vieta E, Fornaro M, Perugi G. Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants. J Affect Disord 2015; 173: 211-5.
Baldwin DS. The importance of long-term tolerability in achieving recovery Int J Psychiatry Clin Pract 2006; 10(sup1): 31-7
Jenike MA. Severe hair loss associated with fluoxetine use. Am J Psychiatry 1991; 148(3): 392.
Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother 1999; 33(5): 631-7.
Bliss SA, Warnock JK. Psychiatric medications: Adverse cutaneous drug reactions. Clin Dermatol 2013; 31(1): 101-9.
Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12(1): 35-42.
Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ, Rodriguez-Pichardo A. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata. Int J Dermatol 1999; 38(10): 798-9.
Abedini H, Farshi S, Mirabzadeh A, Keshavarz S. Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat 2014; 25(2): 153-5.
Gupta S, Masand PS. Citalopram and hair loss. Prim Care Companion J Clin Psychiatry 2000; 2(2): 61-2.
Hedenmalm K, Sundström A, Spigset O. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Pharmacoepidemiol Drug Saf 2006; 15(10): 719-25.
Seifritz E, Hatzinger M, Müller MJ, Hemmeter U. Hair loss associated with fluoxetine but not with citalopram. Can J Psychiatry 1995; 40(6): 362.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
Potter WZ, Ketter TA. Pharmacological issues in the treatment of bipolar disorder: Focus on mood-stabilizing compounds. Can J Psychiatry 1993; 38(3)(Suppl. 2): S51-6.
Lin RL, Garibyan L, Kimball AB, Drake LA. Systemic causes of hair loss. Ann Med 2016; 48(6): 393-402.
Warnock JK. Psychotropic medication and drug-related alopecia. Psychosomatics 1991; 32(2): 149-52.
Pillans PJ, Woods DJ. Drug‐Associated Alopecia. Int J Dermatol 1995; 34(3): 149-58.
Guzmán-Sánchez D, Asz-Sigall D. Alopecias due to drugs and other skin and systemic disorders. Curr Probl Dermatol 2015; 47: 97-106.
Goldstein BJ, Goodnick PJ. Selective serotonin reuptake inhibitors in the treatment of affective disorders-III Tolerability, safety and pharmacoeconomics J Psychopharmacol 1998; 12(4_suppl): 55-S87
Rebora A. Changes in growth and distribution of hair associated with psychotropic drug use. CNS Drugs 1997; 8(4): 323-34.
Ferguson JM. SSRI antidepressant medications: Adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001; 3(1): 22-7.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy